Baumeister, T., Proaño-Vasco, A., Metwaly, A., Kleigrewe, K., Kuznetsov, A., Schömig, L. R., . . . Quante, M. (2025). Loss of FXR or bile acid-dependent inhibition accelerate carcinogenesis of gastroesophageal adenocarcinoma. Cellular and Molecular Gastroenterology and Hepatology, 19(8), . https://doi.org/10.1016/j.jcmgh.2025.101505
Chicago-Zitierstil (17. Ausg.)Baumeister, Theresa, et al. "Loss of FXR or Bile Acid-dependent Inhibition Accelerate Carcinogenesis of Gastroesophageal Adenocarcinoma." Cellular and Molecular Gastroenterology and Hepatology 19, no. 8 (2025). https://doi.org/10.1016/j.jcmgh.2025.101505.
MLA-Zitierstil (9. Ausg.)Baumeister, Theresa, et al. "Loss of FXR or Bile Acid-dependent Inhibition Accelerate Carcinogenesis of Gastroesophageal Adenocarcinoma." Cellular and Molecular Gastroenterology and Hepatology, vol. 19, no. 8, 2025, https://doi.org/10.1016/j.jcmgh.2025.101505.